Published • loading... • Updated
Timing Errors May Skew GLP-1RA Cardiovascular Risk Studies, Letter Warns
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Timing Errors May Skew GLP-1RA Cardiovascular Risk Studies, Letter Warns
A new letter to the editor published in the Journal of Clinical Sleep Medicine is drawing attention to a subtle but consequential methodological problem that may distort real-world studies of glucagon-like peptide receptor agonists, the blockbuster class of drugs that includes semaglutide and tirzepatide. Written by Güney Sarıoğlu, a cardiologist at Battalgazi State Hospital in […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
